Articles tagged "Outcome"

2018 American Transplant Congress
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient, Pancreas and Kidney Allograft Survival in Long-Term Follow-Up after Simultaneous Pancreas-Kidney Transplantation
T. Schachtner,^1,2,3 M. Zaks,¹ A. Kahl,¹ P. Reinke.^1,2
¹Nephrology and Internal Intensive Care, Charite Campus Virchow Clinic, Berlin, Germany; ²Berlin-Brandenburg Center for Regenerative Therapies, Charite Campus Virchow Clinic, Berlin, Germany; ³Berlin Institute of Health BIH, Charite and Max Delbrueck Center, Berlin, Germany.
Despite rapid medical advancements in the field of transplantation, mean allograft survival remained at a standstill. If and to what extent a highly specialized and…
2018 American Transplant Congress
Heart Transplantation in Patients with Complex Congenital Heart Disease
M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, D. Geft, D. Chang, L. Czer, J. Kobashigawa, R. Garg, E. Zahn.
Cedars Sinai Medical Center, Los Angeles.
Purpose: As medical and surgical management of complex congenital heart disease (CCHD) improves, patients may survive into adulthood to suffer from end-stage heart failure and…
2018 American Transplant Congress
A Mobile App to Improve Medication Adherence in Kidney Transplant Recipients – Analysis of a Prospective Interventional Study
F. Halleck, S. Georgi, D. Khadzhynov, D. Schmidt, E. Schrezenmeier, L. Lehner, P. Glander, K. Budde, O. Staeck.
Department of Nephrology and Medical Intensive Care, Charité University Berlin, Berlin, Germany.
Background: Non-adherence to medication is one of the leading problems for poor long-term outcome in kidney transplant recipients (KTR). Here we analyze the impact of…
2018 American Transplant Congress
Early Graft Function Correlates with Survival Benefit in Kidney Transplant Recipients with Peripheral Vascular Disease
E. Min, V. Tatapudi, N. Ali, B. Gelb, N. Dagher, J. Benstein, R. Montgomery, B. Lonze.
NYU Langone Medical Center, New York, NY.
Objective: Peripheral vascular disease (PVD) is common among end-stage renal disease (ESRD) patients and is a known independent risk factor for increased post-transplant mortality. The…
2018 American Transplant Congress
Specialized Transplant Critical Care Model Improves Access to Transplantation and Short-Term Survival Outcomes after Liver Transplantation in the Highest Acuity Patients
M. Selim,¹ M. Zimmerman,¹ J. Kim,¹ T. Pearson,¹ C. Eriksen,¹ M. Wong,¹ B. Boettcher,² K. Regner,³ K. Saeian,⁴ H. Woehlk,² J. Hong.¹
¹Department of Surgery, Division of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI; ²Department of Anesthesia, Medical College of Wisconsin, Milwaukee, WI; ³Department of Medicine, Division of Nephrology, Medical College of Wisconsin, Milwaukee, WI; ⁴Department of Medicine, Division of Gastroenterology, Medical College of Wisconsin, Milwaukee, WI.
Objective: Liver transplantation (LT) is a lifesaving treatment for end stage liver disease (ESLD). High acuity ESLD patients are disadvantaged as they are frequently denied…
2018 American Transplant Congress
Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review
Y. AlJishi, M. Bosaeed, S. Husain, C. Rotstein, A. Humar, D. Kumar.
Transplant Infectious Diseases, UHN, Toronto, ON, Canada.
Introduction:Screening and therapy of latent tuberculosis infection (LTBI) is recommended in transplant candidates. However, data on therapy of LTBI with fluoroquinolones are limited. We aimed…
2018 American Transplant Congress
Pre-Existing Allograft Diabetic Nephropathy from Diabetic Donor is Reversible after Kidney Transplantation in Non-Diabetic Recipient
K. Hotta,¹ D. Iwami,¹ H. Harada,² Y. Fukasawa,² H. Okada,¹ H. Higuchi,¹ T. Hirose,² N. Fukuzawa,² N. Shinohara.¹
¹Hokkaido University Hospital, Sapporo, Japan; ²Sapporo City General Hospital, Sapporo, Japan.
【Introduction】The shortage of kidney donor has limited the treatment of patients with end-stage kidney disease. To use diabetic donor with normal renal function is would…
2018 American Transplant Congress
Laparoscopic Donor Nephrectomy Safety: Experience of 500 Cases in Hispanic Population at a Single Institution
Y. Baez Suarez, F. Giron Luque, J. Amaya Nieto.
Transplantation Surgery, Colombiana de Trasplantes, Bogota, Colombia.
Background: Laparoscopic live donor nephrectomy (LDN) has become the best option in living donation because its safety and low rate of complications. This report aims…
2018 American Transplant Congress
Identification of Exosomal Isletokines Released by Pancreatic Islets in Response to Inflammatory Stress
P. Saravanan,¹ G. Yoshimatsu,¹ R. Bhattacharjee,¹ C. Chang,¹ C. Darden,¹ B. Naziruddin,² M. Lawrence.¹
¹Islet Cell Lab, Baylor Scott & White Research Institute, Dallas, TX; ²Transplantation, Baylor Simmons Transplant Institute, Dallas, TX.
Purpose: To identify isletokines released by exosomes from human islets that have been exposed to hypoxic or inflammatory conditions and define stress signaling pathways that…
2018 American Transplant Congress
Factors Associated with the Development of Chronic Kidney Disease after Liver Transplantation
M. Kalisvaart, A. Schlegel, P. Trivedi, K. Roberts, D. Mirza, T. Perera, J. Isaac, J. Ferguson, P. Muiesan.
Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.
BackgroundRenal dysfunction is a common complication after liver transplantation. The increased use of DCD livers has been associated with postoperative acute kidney injury (AKI). However,…